AU2018903056A0 - Derivatives of n-(pyridin-3-yl)pyrimidin-2-amine and their use as inhibitors of protein kinases - Google Patents

Derivatives of n-(pyridin-3-yl)pyrimidin-2-amine and their use as inhibitors of protein kinases

Info

Publication number
AU2018903056A0
AU2018903056A0 AU2018903056A AU2018903056A AU2018903056A0 AU 2018903056 A0 AU2018903056 A0 AU 2018903056A0 AU 2018903056 A AU2018903056 A AU 2018903056A AU 2018903056 A AU2018903056 A AU 2018903056A AU 2018903056 A0 AU2018903056 A0 AU 2018903056A0
Authority
AU
Australia
Prior art keywords
pyrimidin
pyridin
inhibitors
amine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018903056A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Australia
Original Assignee
University of South Australia
Filing date
Publication date
Application filed by University of South Australia filed Critical University of South Australia
Publication of AU2018903056A0 publication Critical patent/AU2018903056A0/en
Abandoned legal-status Critical Current

Links

AU2018903056A 2018-08-20 Derivatives of n-(pyridin-3-yl)pyrimidin-2-amine and their use as inhibitors of protein kinases Abandoned AU2018903056A0 (en)

Publications (1)

Publication Number Publication Date
AU2018903056A0 true AU2018903056A0 (en) 2018-08-30

Family

ID=

Similar Documents

Publication Publication Date Title
EP3700527A4 (en) Papd5 inhibitors and methods of use thereof
EP3684361A4 (en) Substituted inhibitors of menin-mll and methods of use
EP3810617A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3962479A4 (en) Kcnt1 inhibitors and methods of use
EP3962481A4 (en) Kcnt1 inhibitors and methods of use
EP3621615A4 (en) Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
EP3983386A4 (en) Acss2 inhibitors and methods of use thereof
EP3735242A4 (en) Metallo-beta-lactamase inhibitors and methods of use thereof
EP3765006A4 (en) Arginase inhibitors and methods of use
EP3773591A4 (en) Axl kinase inhibitors and use of the same
EP3142652A4 (en) Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
EP3609882A4 (en) Heterocyclic inhibitors of pcsk9
EP3810615A4 (en) Arginase inhibitors and methods of use
EP3919490A4 (en) Five-and-six-membered heterocyclic compound and use thereof as protein receptor kinase inhibitor
EP3508482A4 (en) Inhibitors of fibroblast growth factor receptor and use thereof
EP3846808A4 (en) Papd5 inhibitors and methods of use thereof
EP3755337A4 (en) Pharmaceutical combinations of egfr inhibitors and methods of use thereof
EP3986894A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3897622A4 (en) Arginase inhibitors and methods of use
EP3893879A4 (en) Pyrazolopyridine inhibitors of c-jun-n-terminal kinases and uses thereof
EP3728268A4 (en) Nek inhibitors and methods of use
EP3924351A4 (en) Formulations comprising heterocyclic protein kinase inhibitors
EP3746430A4 (en) Inhibitors of protein arginine deiminases
EP3755689A4 (en) Inhibitors of egfr and methods of use thereof
EP3678660A4 (en) Trpc5 inhibitors and methods of using same